Kansas lawmakers are debating whether to expand health care providers’ access to the federal 340B drug pricing program. If passed, Senate Bill 284 would hand even more power to large hospital chains while shrinking consumer choice. It would also deepen the program’s existing problems — lack of accountability, rising costs, and market consolidation — all […]